Table 1 Patients and clinicopathological characteristics
Variables | No. of patients | % |
|---|---|---|
Age (median, IQR) | 58 (51–65) |  |
Gender (male) | 282 | 60.3 |
Smoking (yes) | 132 | 28.2 |
Drinking (yes) | 66 | 14.1 |
HBsAg (positive) | 202 | 43.2 |
ALT (U/L) (median, IQR) | 29 (16–59) |  |
ALB (g/L) (median, IQR) | 38.4 (34.9–41.0) |  |
TBIL (μmol/L) (median, IQR) | 13.4 (8.9–22.4) |  |
Child–Pugh grade (B) | 126 | 26.9 |
Cirrhosis (yes) | 222 | 47.4 |
LMR (median, IQR) | 3.3 (2.1–4.8) |  |
NLR (median, IQR) | 2.4 (1.7–3.7) |  |
PLR (median, IQR) | 154.8 (102.0–245.3) |  |
AFP (μg/L) (median, IQR) | 3.3 (2.3–10.7) |  |
CEA (μg/L) (median, IQR) | 2.8 (1.7–4.4) |  |
CA19-9 (U/mL) (median, IQR) | 74.3 (21.9–590.4) |  |
Tumor number (multiple) | 107 | 22.9 |
Tumor diameter (> 5 cm) | 208 | 44.4 |
VI (yes) | 100 | 21.4 |
Lymph node metastasis (yes) | 158 | 33.8 |
Tumor differentiation | ||
 Well | 36 | 7.7 |
 Moderate | 346 | 73.9 |
 Poor | 86 | 18.4 |
Type of hepatectomy (major) | 256 | 54.7 |
Blood transfusion (yes) | 134 | 28.6 |
Adjuvant chemotherapy (yes) | 90 | 19.2 |